Italia -
italiano -
Ministero della Salute
solantel
norbrook laboratories ltd - closantel - closantel - 50 mg/ml - closantel
Italia -
italiano -
Ministero della Salute
seponver plus
elanco gmbh - closantel, mebendazolo - closantel - 50 mg; mebendazolo - 75 mg, mebendazolo - 75 mg; closantel - 50 mg - praziquantel, combinazioni
Italia -
italiano -
Ministero della Salute
closamectin pour-on
norbrook laboratories (ireland) limited - closantel, ivermectina - closantel - 200 milligrammi/millilitro (mg/ml); ivermectina - 5 milligrammi/millilitro (mg/ml), ivermectina - 5 mg/ml; closantel - 200 mg/ml, closantel - 200 mg/ml; ivermectina - 5 mg/ml - ivermectin, combinations
Italia -
italiano -
Ministero della Salute
oxydrench
norbrook laboratories (ireland) limited - oxfendazolo, closantel - oxfendazolo - 25 milligrammo (i); closantel - 50 milligrammo (i), closantel - nd ; oxfendazolo - 25 mg, closantel - 50 mg; oxfendazolo - 25 mg, oxfendazolo - 25 mg; closantel - 50 mg - oxfendazole, combinations
Italia -
italiano -
Ministero della Salute
oramec
boehringer ingelheim animal health italia s.p.a - ivermectina - ivermectina - 0.08 g - ivermectin
Italia -
italiano -
Ministero della Salute
tolomec o.s.
fatro s.p.a. - ivermectina - ivermectina - 0.8 mg - ivermectin
Unione Europea -
italiano -
EMA (European Medicines Agency)
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - agenti antineoplastici - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
merfen colorante per l'applicazione sulla pelle
verfora sa - benzoxonii chloridum, chlorhexidini digluconas - colorante per l'applicazione sulla pelle - benzoxonii chloridum 1 mg, chlorhexidini digluconas 5 mg alcol isopropylicus 394 mg, propylenglycolum, excipiens ad una soluzione per 1 ml. - disinfezione di ferite - synthetika